SE451850B - Sett att framstella ett glykoprotein med kend formaga att stimulera bildning och differentiering av humana granulocyter - Google Patents
Sett att framstella ett glykoprotein med kend formaga att stimulera bildning och differentiering av humana granulocyterInfo
- Publication number
- SE451850B SE451850B SE8005256A SE8005256A SE451850B SE 451850 B SE451850 B SE 451850B SE 8005256 A SE8005256 A SE 8005256A SE 8005256 A SE8005256 A SE 8005256A SE 451850 B SE451850 B SE 451850B
- Authority
- SE
- Sweden
- Prior art keywords
- medium
- glycoprotein
- csf
- human
- serum
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9235579A JPS5618591A (en) | 1979-07-20 | 1979-07-20 | Production of substance capable of differentiation and multiplication of stem cells of human granulocyte |
JP6462580A JPS56160994A (en) | 1980-05-15 | 1980-05-15 | Preparation of substance capable of differentiating and multiplying human granulocytic stem cell |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8005256L SE8005256L (sv) | 1981-01-21 |
SE451850B true SE451850B (sv) | 1987-11-02 |
Family
ID=26405712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8005256A SE451850B (sv) | 1979-07-20 | 1980-07-18 | Sett att framstella ett glykoprotein med kend formaga att stimulera bildning och differentiering av humana granulocyter |
Country Status (7)
Country | Link |
---|---|
US (1) | US4342828A (no) |
CA (1) | CA1128881A (no) |
CH (1) | CH644520A5 (no) |
DE (1) | DE3027105A1 (no) |
FR (1) | FR2461500A1 (no) |
GB (1) | GB2058081B (no) |
SE (1) | SE451850B (no) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6030654B2 (ja) * | 1980-12-31 | 1985-07-17 | 株式会社林原生物化学研究所 | ヒトコロニ−刺激因子の製造方法 |
DE3110611A1 (de) * | 1981-03-18 | 1982-10-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | "mitogene der leukozyten und des entzuendungsgewebes:natuerliche leukopoetine zur selektiven anregung der teilung und differenzierung von leukozyten" |
US4432751A (en) * | 1982-03-05 | 1984-02-21 | Baylor College Of Medicine | Monoclonal antibodies against lens epithelial cells and preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
JPS59137417A (ja) * | 1983-01-28 | 1984-08-07 | Morinaga Milk Ind Co Ltd | 人尿由来コロニ−形成刺激因子及びカリクレインの製造法 |
JPS61227526A (ja) * | 1984-07-25 | 1986-10-09 | Chugai Pharmaceut Co Ltd | 新規なコロニー刺激因子 |
UA29377C2 (uk) * | 1984-09-19 | 2000-11-15 | Новартіс Аг | Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів |
US5556620A (en) * | 1985-02-05 | 1996-09-17 | Cetus Oncology Corporation | Use of recombinant colony stimulating factor-1 to enhance wound healing |
WO1986004607A1 (en) * | 1985-02-05 | 1986-08-14 | Cetus Corporation | Recombinant colony stimulating factor-1 |
US5573930A (en) * | 1985-02-05 | 1996-11-12 | Cetus Oncology Corporation | DNA encoding various forms of colony stimulating factor-1 |
US5422105A (en) * | 1985-02-05 | 1995-06-06 | Cetus Oncology Corporation | Use of recombinant colony stimulating factor 1 |
US6156300A (en) * | 1985-02-05 | 2000-12-05 | Chiron Corporation | Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof |
US5104650A (en) * | 1985-02-05 | 1992-04-14 | Cetus Corporation | Uses of recombinant colony stimulating factor-1 |
US6103224A (en) * | 1985-02-05 | 2000-08-15 | Chiron Corporation | N∇2 CSF-1 (short form) and carboxy truncated fragments thereof |
US5792450A (en) * | 1985-02-05 | 1998-08-11 | Chiron Corporation | Purified human CSF-1 |
US4847201A (en) * | 1985-02-05 | 1989-07-11 | Cetus Corporation | DNA encoding for CSF-1 and accompanying recombinant systems |
US5837229A (en) * | 1985-02-05 | 1998-11-17 | Chiron Corporation | Uses of recombinant colony stimulating factor-1 |
JPH0753667B2 (ja) * | 1985-08-09 | 1995-06-07 | 新技術開発事業団 | 骨髄移植療法補助剤 |
US5078996A (en) * | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5510254A (en) * | 1986-04-18 | 1996-04-23 | Advanced Tissue Sciences, Inc. | Three dimensional cell and tissue culture system |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5160490A (en) * | 1986-04-18 | 1992-11-03 | Marrow-Tech Incorporated | Three-dimensional cell and tissue culture apparatus |
US4721096A (en) * | 1986-04-18 | 1988-01-26 | Marrow-Tech Incorporated | Process for replicating bone marrow in vitro and using the same |
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US5055291A (en) * | 1986-11-04 | 1991-10-08 | Baylor College Of Medicine | Compositions for preventing secondary cataracts |
US4871350A (en) * | 1986-11-04 | 1989-10-03 | Baylor College Of Medicine | Methods and compositions for preventing secondary cataracts |
JPS63245667A (ja) * | 1987-03-31 | 1988-10-12 | Ube Ind Ltd | 肥満細胞成長活性を有するヒトil−3産生ヒト細胞および肥満細胞成長活性を有するヒトil−3の製造方法 |
EP0643972B1 (en) * | 1987-09-22 | 2002-03-06 | Chiron Corporation | Use of recombinant colony stimulating factor-1 for the preparation of a medicament for cytomegalovirus infections |
US5190876A (en) * | 1988-12-27 | 1993-03-02 | Emory University | Method of modifying cellular differentiation and function and compositions therefor |
CA2080693C (en) * | 1990-04-24 | 2001-11-27 | Mark Eisenberg | Composite living skin equivalents |
US6211146B1 (en) | 1991-03-11 | 2001-04-03 | Curis, Inc. | 60A protein-induced morphogenesis |
US5652337A (en) * | 1991-03-11 | 1997-07-29 | Creative Biomolecules, Inc. | OP-3-induced morphogenesis |
CA2363965C (en) | 1991-03-11 | 2010-05-18 | Curis, Inc. | Protein-induced morphogenesis |
US5460964A (en) * | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
US5436151A (en) * | 1992-04-03 | 1995-07-25 | Regents Of The University Of Minnesota | Method for culturing human hematopoietic stem cells in vitro |
IL110195A (en) * | 1994-07-03 | 2003-10-31 | David Danon | Method and system for cultivating macrophages |
US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
EP0980252B1 (en) | 1997-05-05 | 2004-10-06 | Curis, Inc. | Therapies for acute renal failure |
US8435939B2 (en) * | 2000-09-05 | 2013-05-07 | Biokine Therapeutics Ltd. | Polypeptide anti-HIV agent containing the same |
WO2004020462A1 (ja) | 2002-08-27 | 2004-03-11 | Fujii, Nobutaka | Cxcr4拮抗薬およびその用途 |
US8029985B2 (en) * | 2004-09-01 | 2011-10-04 | Vybion, Inc. | Amplified bioassay |
CA2673719C (en) * | 2006-12-21 | 2018-07-24 | Biokine Therapeutics Ltd. | T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery |
US9155780B2 (en) | 2009-02-11 | 2015-10-13 | Yeda Research And Development Co. Ltd. | Short beta-defensin-derived peptides |
US9427456B2 (en) | 2009-06-14 | 2016-08-30 | Biokine Therapeutics Ltd. | Peptide therapy for increasing platelet levels |
WO2013160895A1 (en) | 2012-04-24 | 2013-10-31 | Biokine Therapeutics Ltd. | Peptides and use thereof in the treatment of large cell lung cancer |
WO2017009843A2 (en) | 2015-07-16 | 2017-01-19 | Biokine Therapeutics Ltd. | Compositions, articles of manufacture and methods for treating cancer |
BR112018016924A2 (pt) | 2016-02-23 | 2019-01-02 | Biokine Therapeutics Ltd | método de seleção de regime de tratamento para indivíduo que tem leucemia mieloide aguda (lma), método de maximização de resposta ao tratamento de leucemia mieloide aguda (lma), método de tratamento de lma, antagonista de cxcr4 e agente quimioterápico no tratamento de lma |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4135975A (en) * | 1977-12-14 | 1979-01-23 | Lichtman Marshall A | Obtaining human cell lines that elaborate colony stimulating activity for marrow cells of man and other species and methods of preparing same |
JPS6030291B2 (ja) * | 1978-03-20 | 1985-07-16 | 森永乳業株式会社 | 人顆粒球の分化増殖を促進するhgi糖蛋白質、hgi糖蛋白質の製造法及びhgi糖蛋白質を含有する白血球減少症治療剤 |
AU523077B2 (en) * | 1978-03-20 | 1982-07-08 | Green Cross Corporation, The | Hgi glycoprotein |
-
1980
- 1980-07-15 US US06/169,107 patent/US4342828A/en not_active Expired - Lifetime
- 1980-07-17 CA CA356,422A patent/CA1128881A/en not_active Expired
- 1980-07-17 GB GB8023347A patent/GB2058081B/en not_active Expired
- 1980-07-17 DE DE19803027105 patent/DE3027105A1/de active Granted
- 1980-07-18 FR FR8015923A patent/FR2461500A1/fr active Granted
- 1980-07-18 SE SE8005256A patent/SE451850B/sv not_active IP Right Cessation
- 1980-07-18 CH CH550580A patent/CH644520A5/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1128881A (en) | 1982-08-03 |
FR2461500B1 (no) | 1984-02-17 |
DE3027105C2 (no) | 1988-08-25 |
CH644520A5 (de) | 1984-08-15 |
US4342828A (en) | 1982-08-03 |
GB2058081A (en) | 1981-04-08 |
DE3027105A1 (de) | 1981-02-12 |
SE8005256L (sv) | 1981-01-21 |
FR2461500A1 (fr) | 1981-02-06 |
GB2058081B (en) | 1983-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE451850B (sv) | Sett att framstella ett glykoprotein med kend formaga att stimulera bildning och differentiering av humana granulocyter | |
CA1068601A (en) | Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same | |
Den et al. | Influence of Concanavalin A, wheat germ agglutinin, and soybean agglutinin on the fusion of myoblasts in vitro. | |
Burke | The purification of interferon | |
GB2134528A (en) | Method of isolation of colony-stimulating factor and kallikrein originating from human urine | |
FI72143B (fi) | Foerfarande foer framstaellning av maenniskointerferon | |
Coyne et al. | Guinea Pig Lymphotoxin (LT) II. Physicochemical Properties of LT Produced by Lymphocytes Stimulated with Antigen or Concanavalin A: Its Differentiation from Migration-Inhibitory Factor (MIF) | |
CA1063019A (en) | Extracts of the haemopoietic system | |
Lehmann et al. | Haemoglobin E in Burmese | |
US3975344A (en) | Interferon purification | |
CN113801219A (zh) | 一种转铁蛋白的制备方法及包含转铁蛋白的组合物和应用 | |
Hammar et al. | Induction of tubuloreticular structures in cultured human endothelial cells by recombinant interferon alfa and beta | |
CN110724176B (zh) | 一种治疗阿尔茨海默症的血浆蛋白分离物及其制备方法和应用 | |
CN110787187B (zh) | 一种增强记忆力和提高认知功能的血浆混合物及其制备方法和应用 | |
RU2204262C2 (ru) | Способ получения биологически активного белкового концентрата, обогащенного панкреатической рибонуклеазой а, ангиогенином и лизоцимом, из молочного ультрафильтрата | |
SE451844B (sv) | Glykoprotein, forfarande for framstellning derav samt terapeutiskt medel innehallande nemnda glykoprotein | |
JP2787220B2 (ja) | ウィルス感染防御剤 | |
JPS6041615A (ja) | コロニ−形成刺激因子の製造方法 | |
HRP20140247T1 (hr) | Cjepivo protiv raka | |
AT391482B (de) | Verfahren zur industriellen herstellung von hochreinem menschlichem leukozyteninterferon | |
JPS6237605B2 (no) | ||
EP0407092A1 (en) | Lymphocyte-activating factor, method for the preparation thereof and method for the proliferation of antibody-forming lymphocytes and production of antibody using the same | |
JP4581082B2 (ja) | 自己免疫増強剤、その製造方法及びそれを用いた化粧料 | |
Kutsky | GROWTH-STIMULATING EFFECTS BY NUCLEO-PROTEIN AND CELL FRACTIONS ON CHICK HEART FIBROBLASTS IN VITRO | |
EP0396597A1 (de) | Verfahren zur herstellung eines therapeutisch aktiven, insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes und ein einen solchen wirkstoff enthaltendes therapeutisches präparat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8005256-6 Effective date: 19940210 Format of ref document f/p: F |